Announcing Vetro
VitVio opens access to Vetro, its 3D-native AI platform for operating room intelligence, to hospitals and health systems
- Vetro is the world's only 3D-native AI platform for operating rooms, giving hospitals a live picture of what's happening in surgery, when, where and why
- Powered by VitVio's Spatial Context Engine, Vetro automates reports, orchestrates teams, cuts waste and frees clinicians to focus on patient care
- Having worked with leading hospitals in New York, LA and London, Vetro is now officially opening access widely to hospitals and health systems across the US, Europe, Latin America, the UK and the Middle East with more regions to follow
Boston, MA, 23rd July: Having proven its impact in select operating rooms across the US, Europe and UK, VitVio is now officially opening access to Vetro, its 3D-native AI platform for operating room intelligence, to hospitals and health systems.
Unlike 2D systems, which only capture basic surgical steps and still need manual entry, Vetro uses a multi-camera system, ambient sensing and computer vision to continuously feed 3D data to VitVio’s Spatial Context Engine. It uses this data to build live spatial maps while its AI turns every movement of people, instruments and equipment into a live, structured record of what's happening, when, where and why.
Whether it’s detecting when cases start and end, flagging delays, orchestrating staff, cutting tool waste or automating reports, Vetro removes the guesswork behind wasted, underused and unplanned theatre time to get more patients into surgery and cut waiting times. All of this is done while respecting staff and patient privacy. Performing just one additional hour-long case a day has been shown to increase a single operating suite's profitability by $300,000 a year, while hospitals using Vetro can see profitability rise 23% (depending on hospital and procedure type.)
By focusing on processes rather than people, all data is anonymised at the point of capture, in a system that's fully compliant.
World’s first and only 3D clinical sensing system
With today’s launch, Vetro is now open to hospitals and health systems across the US, Europe, Latin America, the UK and the Middle East with more regions to follow.
Thomas Knox, Co-Founder and CEO, VitVio, said: "We've spent two years building out Vetro to work under real pressure, in real operating rooms. Now it's time to bring the impact our early partners are seeing to hospitals and health systems around the world.”
Founded in 2024 by Thomas Knox, Dr Peter Rennert, Maks Kozarzewski and Aleks Pajewski, VitVio previously announced a partnership with the Royal Orthopaedic Hospital NHS Foundation Trust. Its Vetro platform is now live in theatres across the US and the UK, and its new partners include leading oncology and orthopaedic centers in New York, private hospital groups in LA and London, and NHS teaching hospitals. Further announcements are due to follow in the coming months.
